China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China flag China · Delayed Price · Currency is CNY
18.79
-0.01 (-0.69%)
May 14, 2025, 9:45 AM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Non-Transfusion
7.03B
Log In
Log In
Log In
Log In
Non-Transfusion Growth
2.62%
Log In
Log In
Log In
Log In
Transfusion
3.31B
Log In
Log In
Log In
Log In
Transfusion Growth
23.20%
Log In
Log In
Log In
Log In
Inter-segment Eliminations
-120.97M
Log In
Log In
Log In
Log In
Inter-segment Eliminations Growth
30.41%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
China
10.22B
Log In
Log In
Log In
Log In
China Growth
15.76%
Log In
Log In
Log In
Log In
Other Countries
-
Log In
Log In
Log In
Log In
United States
-
Log In
Log In
Log In
Log In